jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacology and PharmacotherapeuticsNOW IN
Article

Angioedema due to fixed dose combination of telmisartan plus ramipril

Vishal R. Tandon1★, Annil Mahajan2, Vijay Khajuria1, Zahid H. Gillani1★ Corresponding author

  1. 1Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.
  2. 2Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India Case Report.

CORRESPONDENCE

Vishal R. Tandon

Department of Pharmacology and Therapeutic, College, Jammu, Jammu and Kashmir, India Case Report.

Received: 03-08-2013; Revised: 20-11-2013; Accepted: 16-01-2014.

Volume 5, Issue 3 · pp. 214–216 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.136113

View on JPP original site ↗

ABSTRACT

The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin‑converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Tandon, V. R., Mahajan, A., Khajuria, V., & Gillani, Z. H. (2014). Angioedema due to fixed dose combination of telmisartan plus ramipril. Journal of Pharmacology and Pharmacotherapeutics, 5(3), 214–216. https://doi.org/10.4103/0976-500X.136113